Tectonic Therapeutic, Inc. Ratios

Ratios Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin 84,094.34%81,072.22%58,971.43%195,288.52%67,445.86%29,091.45%50,337.38%
EBIT Margin 87,250.94%84,232.22%59,225.62%194,821.31%67,155.41%29,373.68%54,219.63%
EBITDA Margin 87,473.58%81,072.22%58,971.43%195,288.52%67,155.41%29,373.68%54,219.63%
Operating Margin 87,250.94%84,232.22%59,225.62%194,821.31%67,155.41%29,373.68%54,219.63%
Net Margin 91,705.66%81,072.22%58,971.43%195,288.52%67,445.86%28,173.03%54,188.79%
FCF Margin 74,490.57%76,947.78%49,251.23%164,731.15%62,085.99%26,947.37%55,360.75%
Leverage & Solvency
Interest Coverage Ratio -872.51-842.32-592.26-0.00M-671.55-293.74-542.20
Times Interest Earned -872.51-842.32-592.26-0.00M-671.55-293.74-542.20
Valuation
Enterprise Value 398.87M637.47M508.13M168.06M31.21M60.62M681.13M
Market Capitalization 398.87M637.47M508.13M168.06M31.21M60.62M681.13M
Return Ratios
Return on Sales 840.94%810.72%589.71%674.46%293.39%503.37%